German CRO SocraTec R&D celebrates 25th anniversary with a series of workshops
(firmenpresse) - 2023 is the year of CRO SocraTec’s 25th anniversary and SocraTec is going to celebrate this in various ways. Therefore SocraTec organizes a journey through various fields of its broad expertise by offering a series of workshops.
All these workshops will take place in the Frankfurt Airport Club which is easily accessible for all guests. But for those who cannot participate in person the workshop will be realized as hybrid meeting.
Of course, on a journey like this, bioequivalence studies should not be missing - after all, they have been with SocraTec since the date of its foundation. Also a tutorial excursions into the exciting development options of biosimilars and biologics will be presented. Besides guests can take a scientifically motivated look at diverse late phases of clinical development – touching of course the field of gynecology – how could it be otherwise.
With this attractive and scientifically exciting series following the motto “www://Experience meets Expertise.de” SocraTec intends to say “Thank You!” to all clients who helped widening its knowledge and expertise by entrusting it with research projects, and to all cooperation partners and scientific friends.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
SocraTec R&D, a mid-sized clinical CRO was founded in 1998. From the beginning the company was dedicated to early phase clinical trials in healthy volunteers, extending the activities towards patients and later phases during their history. The key staff members of the company have far-reaching experience from many years in drug research and development.
From the beginning SocraTec R&D was set-up with a modern quality Quality Management management concept strongly influenced by GLP- and GCP-principles. All processes are embedded in a comprehensive Quality Management under the supervision of a highly experienced and independent QA-group. Biometric services follow the standards of 21 CFR Part 11. SocraTec R&D is frequently audited by all types of pharmaceutical companies and has been inspected by national EU-agencies, EMA and FDA as well as by ANVISA.
SocraTec R&D GmbH
61440 Oberursel
Im Setzling 35
Tel.: ++49 617158571-0
Fax: ++49 61715857-25
info(at)socratec-pharma.de
SocraTec R&D GmbH
Datum: 04.07.2023 - 10:10 Uhr
Sprache: Deutsch
News-ID 686895
Anzahl Zeichen: 1249
contact information:
Contact person: Tessa Paschke-Maier
Town:
Frankfurt
Phone: ++49-6171-58571-0
Kategorie:
Trials
Typ of Press Release: Success
type of sending: send
Date of sending: 04.07.2023
Diese Pressemitteilung wurde bisher 152 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"German CRO SocraTec R&D celebrates 25th anniversary with a series of workshops"
steht unter der journalistisch-redaktionellen Verantwortung von
SocraTec R&D (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
